Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

The effects of statins on the clinical outcomes of Clostridium difficile infection in hospitalised patients.

Park SW, Choi AR, Lee HJ, Chung H, Park JC, Shin SK, Lee SK, Lee YC, Kim JE, Lee H.

Aliment Pharmacol Ther. 2013 Sep;38(6):619-27. doi: 10.1111/apt.12439. Epub 2013 Jul 29.

2.
3.

Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.

Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, Farley MM, Dumyati GK, Wilson LE, Beldavs ZG, Dunn JR, Gould LH, MacCannell DR, Gerding DN, McDonald LC, Lessa FC.

JAMA Intern Med. 2013 Jul 22;173(14):1359-67. doi: 10.1001/jamainternmed.2013.7056.

PMID:
23780507
4.

Proton pump inhibitors as a risk factor for recurrence of Clostridium-difficile-associated diarrhea.

Kim JW, Lee KL, Jeong JB, Kim BG, Shin S, Kim JS, Jung HC, Song IS.

World J Gastroenterol. 2010 Jul 28;16(28):3573-7.

5.

Effect of the prebiotic oligofructose on relapse of Clostridium difficile-associated diarrhea: a randomized, controlled study.

Lewis S, Burmeister S, Brazier J.

Clin Gastroenterol Hepatol. 2005 May;3(5):442-8.

PMID:
15880313
6.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Nelson R.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD004610.

PMID:
17636768
7.

Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis.

Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM.

Am J Health Syst Pharm. 2007 Nov 15;64(22):2359-63.

PMID:
17989446
8.

The effect of statins on the outcome of Clostridium difficile infection in hospitalized patients.

Atamna A, Yahav D, Eliakim-Raz N, Goldberg E, Ben-Zvi H, Barsheshet A, Elis A, Bishara J.

Eur J Clin Microbiol Infect Dis. 2016 May;35(5):779-84. doi: 10.1007/s10096-016-2597-9. Epub 2016 Feb 10.

PMID:
26864041
9.

Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.

Freedberg DE, Salmasian H, Friedman C, Abrams JA.

Am J Gastroenterol. 2013 Nov;108(11):1794-801. doi: 10.1038/ajg.2013.333. Epub 2013 Sep 24.

10.

Clostridium difficile infection in older adults: a review and update on its management.

Kee VR.

Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Review.

PMID:
22260856
11.

Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.

Kim YG, Graham DY, Jang BI.

J Clin Gastroenterol. 2012 May-Jun;46(5):397-400. doi: 10.1097/MCG.0b013e3182431d78.

PMID:
22298089
12.

Do statins protect against the development of Clostridium difficile-associated diarrhoea?

Nseir W, Bishara J, Mograbi J, Mahamid M, Khalaila W, Taha M, Farah R.

J Antimicrob Chemother. 2013 Aug;68(8):1889-93. doi: 10.1093/jac/dkt101. Epub 2013 Apr 5.

PMID:
23563740
13.

Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.

Venugopal AA, Riederer K, Patel SM, Szpunar S, Jahamy H, Valenti S, Shemes SP, Khatib R, Johnson LB.

Scand J Infect Dis. 2012 Apr;44(4):243-9. doi: 10.3109/00365548.2011.631029. Epub 2011 Nov 13.

PMID:
22077148
14.

Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.

King RN, Lager SL.

Pharmacotherapy. 2011 Jul;31(7):642-8. doi: 10.1592/phco.31.7.642.

PMID:
21923450
15.

Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.

Jardin CG, Palmer HR, Shah DN, Le F, Beyda ND, Jiang Z, Garey KW.

J Hosp Infect. 2013 Sep;85(1):28-32. doi: 10.1016/j.jhin.2013.04.017. Epub 2013 Jul 5.

PMID:
23834988
16.

Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease.

Choudhry MN, Soran H, Ziglam HM.

QJM. 2008 Jun;101(6):445-8. doi: 10.1093/qjmed/hcn035. Epub 2008 Apr 14.

PMID:
18411220
17.

Statin use and infections in Veterans with cirrhosis.

Motzkus-Feagans C, Pakyz AL, Ratliff SM, Bajaj JS, Lapane KL.

Aliment Pharmacol Ther. 2013 Sep;38(6):611-8. doi: 10.1111/apt.12430. Epub 2013 Jul 29.

18.

Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Bricker E, Garg R, Nelson R, Loza A, Novak T, Hansen J.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004610. Review. Update in: Cochrane Database Syst Rev. 2007;(3):CD004610.

PMID:
15674956
19.

Effect of age on treatment outcomes in Clostridium difficile infection.

Louie TJ, Miller MA, Crook DW, Lentnek A, Bernard L, High KP, Shue YK, Gorbach SL.

J Am Geriatr Soc. 2013 Feb;61(2):222-30. doi: 10.1111/jgs.12090. Epub 2013 Feb 4.

PMID:
23379974
20.

Supplemental Content

Support Center